EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-SA 4.0

A Patient with Marburg’s Variant of Multiple Sclerosis Responded Well to Cyclophosphamide

Foziah Jabbar Alshamrani, Rawan Salim Alyami

Annals of African Medicine · 2025

DOI: 10.4103/aam.aam_30_24 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of African Medicine, 2025. Verfasst von Foziah Jabbar Alshamrani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, King Fahad University Hospital, Al Khobar, Saudi Arabia. Hauptthemen laut MEDLINE: Cyclophosphamide, Immunosuppressive Agents, Multiple Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marburg’s disease is a fatal variant of multiple sclerosis (MS), distinguished by its fulminant, rapidly progressive monophasic course that often leads to patients’ mortality within weeks of onset. Owing to its rarity, there are no established treatment guidelines. We present a 34 year-old male who was diagnosed with MS, and magnetic resonance imaging revealed numerous supra- and infratentorial white matter plaques. Steroid pulse therapy, intravenous immunoglobulin, and plasma exchange were ineffective. After excluding other differential diagnoses, Marburg’s variant MS was considered, and intravenous cyclophosphamide with methylprednisolone was administered. The patient showed significant and fast clinical improvement adding to the evidence that cyclophosphamide is an effective therapeutic modality for treating this MS variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideImmunosuppressive AgentsMultiple SclerosisHumansMaleAdultTreatment OutcomeMagnetic Resonance ImagingMethylprednisolone

Stichwörter der Autor:innen

CyclophosphamideMarburg’s variantmethylprednisolonemultiple sclerosisméthylprednisolonesclérose en plaquesvariante de Marburg

Substanzen

CyclophosphamideImmunosuppressive AgentsMethylprednisolone

Autor:innen und Institutionen

  • Department of Neurology, King Fahad University Hospital, Al Khobar, Saudi Arabia.
  • Department of Neurology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Zitieren

APA

Alshamrani, F. J., & Alyami, R. S. (2025). A Patient with Marburg’s Variant of Multiple Sclerosis Responded Well to Cyclophosphamide. Annals of African Medicine. https://doi.org/10.4103/aam.aam_30_24

Vancouver

Alshamrani FJ, Alyami RS. A Patient with Marburg’s Variant of Multiple Sclerosis Responded Well to Cyclophosphamide. Annals of African Medicine. 2025. doi:10.4103/aam.aam_30_24

BibTeX
@article{Alshamrani2025,
  author = {Alshamrani, Foziah Jabbar and Alyami, Rawan Salim},
  title = {A Patient with Marburg’s Variant of Multiple Sclerosis Responded Well to Cyclophosphamide},
  journal = {Annals of African Medicine},
  year = {2025},
  doi = {10.4103/aam.aam_30_24}
}
Kostenlos starten →